Novo Holdings-backed KabaFusion completed the acquisition of infusion care assets from Coram.

Novo Holdings-backed KabaFusion, a national home and alternative-site infusion company, completed the acquisition of infusion care assets from Coram, a provider of infusion and tube feeding therapy services. Financial terms were not disclosed. “Our expansion will enable KabaFusion to serve a greater number of patients with superior care. Patient demand for home and ambulatory infusion services continues to increase, and we are thrilled to open new locations to meet the needs of our patients,” Dr. Sohail Masood, KabaFusion Founder and CEO.